Skip to main content
Article
Systemic Irinotecan or Regional Floxuridine Chemotherapy Prolongs Survival After Hepatic Cryosurgery in Patients with Metastatic Colon Cancer Refractory to 5-Fluorouracil
Clinical Colorectal Cancer (2001)
  • Anton J. Bilchik, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, CA
  • Thomas F. Wood, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, CA
  • Sant P. Chawla, Century City Hospital, Los Angeles, CA
  • D. Michael Rose, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, CA
  • Mathew H. Chung, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, CA
  • Stacey S. Stern, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, CA
  • Leland J. Foshag, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, CA
  • Kenneth P. Ramming, Century City Hospital, Los Angeles, CA
Publication Date
May 1, 2001
DOI
10.3816/CCC.2001.n.003
Citation Information
Anton J. Bilchik, Thomas F. Wood, Sant P. Chawla, D. Michael Rose, et al.. "Systemic Irinotecan or Regional Floxuridine Chemotherapy Prolongs Survival After Hepatic Cryosurgery in Patients with Metastatic Colon Cancer Refractory to 5-Fluorouracil" Clinical Colorectal Cancer Vol. 1 Iss. 1 (2001) p. 36 - 42
Available at: http://works.bepress.com/antonj-bilchik/197/